Next Article in Journal
Editorial on Special Issue: “Novel Therapeutic Strategies for Glioblastoma”
Next Article in Special Issue
Physiologically Based Pharmacokinetic Modeling to Assess Perpetrator and Victim Cytochrome P450 2C Induction Risk
Previous Article in Journal
Population Pharmacokinetics and Model-Informed Precision Dosing of Clobazam Based on the Developmental and Genetic Characteristics of Children with Epilepsy
Previous Article in Special Issue
Whole-Body Physiologically Based Pharmacokinetic Modeling Framework for Tissue Target Engagement of CD3 Bispecific Antibodies
 
 
Article

Article Versions Notes

Pharmaceutics 2025, 17(7), 814; https://doi.org/10.3390/pharmaceutics17070814
Action Date Notes Link
article html file updated 31 August 2026 23:17 CEST Update https://www.mdpi.com/1999-4923/17/7/814/html
article html file updated 15 September 2025 07:48 CEST Update -
article html file updated 28 August 2025 08:29 CEST Update -
article html file updated 26 June 2025 11:44 CEST Update -
article html file updated 25 June 2025 11:06 CEST Update -
article html file updated 25 June 2025 10:35 CEST Original file -
article pdf uploaded. 25 June 2025 10:34 CEST Updated version of record https://www.mdpi.com/1999-4923/17/7/814/pdf
article xml uploaded. 25 June 2025 10:34 CEST Update https://www.mdpi.com/1999-4923/17/7/814/xml
article xml file uploaded 25 June 2025 10:34 CEST Original file -
article supplementary file uploaded. 23 June 2025 17:49 CEST - https://www.mdpi.com/1999-4923/17/7/814#supplementary
article pdf uploaded. 23 June 2025 17:49 CEST Version of Record https://www.mdpi.com/1999-4923/17/7/814/pdf-vor
Back to TopTop